Enteral Medical Nutrition Market Size & Share Analysis by 2028
肠内医学营养市场规模预计将从 2021 年的 78.0345 亿美元增至 2028 年的 117.2637 亿美元;预计 2022 年至 2028 年的复合年增长率为 6.0%。
肠内营养 (EN) 适用于无法通过常规食物摄入满足能量和营养需求的患者。肠内摄入相较于肠外营养的优势已得到广泛认可。对于大多数依赖肠内营养的儿科患者来说,适合年龄的富含纤维的标准聚合物配方是合适的选择。
肠内营养市场根据适应症、营养类型、形式、产品、分销渠道、年龄组和地域进行细分。按地域划分,市场大致分为北美、欧洲、亚太地区、中东和非洲以及南美和中美洲。该报告提供了对市场的见解和深入分析,强调了市场趋势和市场动态等参数,以及全球领先市场参与者的竞争分析。
定制研究以满足您的需求
我们可以优化和定制标准产品无法满足的分析和范围。这种灵活性将帮助您获得业务规划和决策所需的准确信息。
肠内医学营养市场:
Enteral Medical Nutrition Market: Strategic Insights
Enteral Medical Nutrition Market
-
![](https://www.theinsightpartners.com/assets/images/rd_int_img/cagr.png)
CAGR (2021 - 2028)
6.0%
-
Market Size 2021
US$ 7.8 Billion
-
Market Size 2028
US$ 11.73 Billion
Market Dynamics
GROWTH DRIVERS
- XXXXXXX
- XXXXXXX
- XXXXXXX
FUTURE TRENDS
- XXXXXXX
- XXXXXXX
- XXXXXXX
OPPORTUNITIES
- XXXXXXX
- XXXXXXX
- XXXXXXX
Key Players
- Abbott Laboratories
- Nutricia
- Fresenius Kabi AG
- B. Braun Melsungen AG
- NESTLE S.A.
- Meiji Holdings Co., Ltd.
- Smartfish AS
- DSM
- Hormel Foods Corporation
Regional Overview
- 北美(美国、加拿大、墨西哥)
- 欧洲(英国、德国、法国、俄罗斯、意大利、欧洲其他地区)
- 亚太地区(中国、印度、日本、澳大利亚、亚太地区其他地区)
- 南美洲和中美洲(巴西、阿根廷、南美洲和中美洲其他地区)
- 中东和非洲(南非、沙特阿拉伯、阿联酋、中东和非洲其他地区)
Market Segmentation
适应症(呼吸系统疾病、癌症、新冠肺炎后遗症、胃肠道疾病、肝功能衰竭等)
营养类型(补充和唯一来源)
形态(粉末、液体和半固体)
产品(标准蛋白质饮食、高蛋白质饮食、果汁类口服营养补充剂等)
Enteral Medical Nutrition Market: Strategic Insights
-
CAGR (2021 - 2028)6.0% -
Market Size 2021
US$ 7.8 Billion -
Market Size 2028
US$ 11.73 Billion
![](https://www.theinsightpartners.com/assets/images/rd_int_img/tip-logo.jpg)
Market Dynamics
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
Key Players
- Abbott Laboratories
- Nutricia
- Fresenius Kabi AG
- B. Braun Melsungen AG
- NESTLE S.A.
- Meiji Holdings Co., Ltd.
- Smartfish AS
- DSM
- Hormel Foods Corporation
Regional Overview
![](https://www.theinsightpartners.com/assets/images/rd_int_img/ig-regional.png)
- 北美(美国、加拿大、墨西哥)
- 欧洲(英国、德国、法国、俄罗斯、意大利、欧洲其他地区)
- 亚太地区(中国、印度、日本、澳大利亚、亚太地区其他地区)
- 南美洲和中美洲(巴西、阿根廷、南美洲和中美洲其他地区)
- 中东和非洲(南非、沙特阿拉伯、阿联酋、中东和非洲其他地区)
Market Segmentation
![](https://www.theinsightpartners.com/assets/images/rd_int_img/cust_bullet_danger.png)
![](https://www.theinsightpartners.com/assets/images/rd_int_img/cust_bullet_warning.png)
![](https://www.theinsightpartners.com/assets/images/rd_int_img/cust_bullet_primary.png)
![](https://www.theinsightpartners.com/assets/images/rd_int_img/cust_bullet_warning.png)
复合年增长率(2021 - 2028 年)6.0%- 2021 年市场规模
78 亿美元 - 2028 年市场规模
117.3 亿美元
![](https://www.theinsightpartners.com/assets/images/rd_int_img/tip-logo.jpg)
市场动态
- 財政部
- 財政部
- 財政部
- 財政部
- 財政部
- 財政部
- 財政部
- 財政部
- 財政部
关键人物;主力;重要一员
- 雅培实验室
- 纽迪西亚
- 费森尤斯卡比公司
- B. Braun Melsungen AG
- 雀巢公司
- 明治控股株式会社
- 智能鱼
- 帝斯曼
- 荷美尔食品公司
区域概况
![](https://www.theinsightpartners.com/assets/images/rd_int_img/ig-regional.png)
- 北美
- 欧洲
- 亚太
- 南美洲和中美洲
- 中东和非洲
市场细分
![](https://www.theinsightpartners.com/assets/images/rd_int_img/cust_bullet_danger.png)
- 呼吸系统疾病
- 癌症
- 新冠肺炎疫情后
- 胃肠道疾病
- 肝衰竭
- 其他的
![](https://www.theinsightpartners.com/assets/images/rd_int_img/cust_bullet_warning.png)
- 补充和唯一来源
![](https://www.theinsightpartners.com/assets/images/rd_int_img/cust_bullet_primary.png)
- 粉末
- 液体
- 半固体
![](https://www.theinsightpartners.com/assets/images/rd_int_img/cust_bullet_warning.png)
- 标准蛋白质饮食
- 高蛋白饮食
- 果汁类口服营养补充剂
- 其他的
- 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。
市场洞察
恶病质患病率增加
恶病质是一种多功能性疾病,可导致体重极度下降、骨骼肌和脂肪组织丢失、代谢调节失衡以及食物摄入减少,是几乎所有慢性疾病进展到晚期时都会出现的严重临床后果。据美国国家生物技术信息中心(NCBI)统计,2016年终末期慢性心力衰竭患者恶病质的患病率为5%~15%,常见于慢性肾脏病、慢性阻塞性肺病、神经系统疾病、类风湿性关节炎等患者。重度COPD患者恶病质的年死亡率为15%~25%,慢性心力衰竭或慢性肾脏病患者恶病质的年死亡率为20%~40%。
癌症恶病质会影响癌症患者的生活质量,降低抗癌化疗的疗效,增加化疗的毒性,导致癌症相关死亡率和医疗资源支出的增长。据Globocan报道,世界卫生组织报告,2018年有960万人死亡,1810万新发癌症病例。此外,癌症恶病质是一种消耗综合征,发生在高达80%的癌症患者中。根据北京呼吸与危重病医学科发表的文章,胰腺癌和胃癌患者恶病质的患病率为87%;结肠癌、肺癌和前列腺癌患者恶病质的患病率为61%;乳腺癌、肉瘤、白血病和霍奇金淋巴瘤患者恶病质的患病率为~40%。此外,20%的癌症相关死亡是由于恶病质造成的。在恶病质中,体内的营养物质减少。因此,需要提供外部营养物质来继续治疗癌症和COPD。医生更倾向于通过肠内途径为患者提供这些所需的营养物质。因此,由于各种慢性疾病发病率上升而导致的恶病质患病率不断上升,推动了肠内医疗营养市场的增长。
指示见解
根据适应症,肠内医学营养市场细分为呼吸系统疾病、癌症、新冠后、胃肠道疾病、肝功能衰竭等。呼吸系统疾病细分市场进一步细分为慢性阻塞性肺病 (COPD)、呼吸衰竭、囊性纤维化等。癌症细分市场细分为癌症恶病质、伴有 COPD 的恶病质等。胃肠道疾病细分市场进一步细分为肠梗阻、短肠梗阻、克罗恩病等。呼吸系统疾病细分市场在 2021 年占据最大市场份额。然而,预计在预测期内,癌症细分市场将录得 7.6% 的最高复合年增长率。雅培生产的 Pulmocare 专为患有 COPD、囊性纤维化或呼吸衰竭的人设计。高热量、改良的碳水化合物和脂肪 肠内配方可以帮助这些患者减少饮食引起的二氧化碳产生。
营养类型洞察
根据营养类型,全球肠内医学营养市场分为补充和单一来源。补充部分在 2021 年占据了更大的市场份额。然而,单一来源部分预计在预测期内将实现更高的复合年增长率。接受补充营养来源的患者必须在医院住院一段时间。为患者提供富含 omega-3 脂肪酸、核糖核酸和谷氨酰胺或精氨酸的肠内配方。例如,Jevity 是一种营养配方,旨在为接受短期或长期管饲方案的成年人提供补充或单一来源的营养。同样的配方的热量密度为每毫升 1.0、1.2 和 1.5 卡路里。Jevity 配方还可以帮助满足患者的日常蛋白质和纤维需求。
表单洞察
根据形式,全球肠内医学营养市场分为粉末、液体和半固体。半固体部分在 2021 年占据了最大的市场份额,预计在预测期内将实现最高的复合年增长率。
产品洞察
根据产品,全球肠内医学营养市场细分为标准蛋白质饮食、高蛋白质饮食、果汁类口服营养品等。2021 年,标准蛋白质饮食部分占据了最大的市场份额。然而,果汁类口服营养品部分预计在预测期内将实现最高的复合年增长率。
分销渠道洞察
根据分销渠道,肠内营养市场分为医院药房、零售店和其他药房。医院药房部分在 2021 年占据了最大的市场份额。然而,预计零售店部分在预测期内的复合年增长率最高。
年龄组洞察
根据年龄,肠内营养市场分为儿童(18 岁以下)和成人(18 岁以上)。2021 年成人(18岁以上)占据了更大的市场份额。然而,儿童(18 岁以下)细分市场预计在预测期内将录得更高的复合年增长率。
肠内医学营养市场报告范围
报告属性 | 细节 |
---|---|
2021 年市场规模 | 78亿美元 |
2028 年市场规模 | 117.3亿美元 |
全球复合年增长率(2021 - 2028) | 6.0% |
历史数据 | 2019-2020 |
预测期 | 2022-2028 |
涵盖的领域 | 按适应症
|
覆盖地区和国家 | 北美
|
市场领导者和主要公司简介 |
|
- 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。
肠内医学营养市场 – 按地区
按地域划分,全球市场分为北美洲(美国、加拿大和墨西哥)、欧洲(英国、德国、法国、意大利、西班牙和欧洲其他地区)、亚太地区(中国、日本、印度、澳大利亚、韩国和亚太地区其他地区)、中东和非洲(阿联酋、沙特阿拉伯、南非和中东和非洲其他地区)以及南美洲和中美洲(巴西、阿根廷和南美洲和中美洲其他地区)。
公司简介
Enteral Medical Nutrition Market Report Scope
Report Attribute | Details |
---|---|
Market size in | US$ 7.8 Billion |
Market Size by | US$ 11.73 Billion |
Global CAGR | 6.0% |
Historical Data | 2019-2020 |
Forecast period | 2022-2028 |
Segments Covered |
By 适应症(呼吸系统疾病、癌症、新冠肺炎后遗症、胃肠道疾病、肝功能衰竭等) |
Regions and Countries Covered |
北美(美国、加拿大、墨西哥)
|
Market leaders and key company profiles |
|
![Report Coverage](https://www.theinsightpartners.com/assets/rdimages/report_coverage.png)
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
![Segment Covered](https://www.theinsightpartners.com/assets/rdimages/segment_covered.png)
Segment Covered
This text is related
to segments covered.
![Regional Scope](https://www.theinsightpartners.com/assets/rdimages/regional_scope.png)
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
![Country Scope](https://www.theinsightpartners.com/assets/rdimages/country_scope.png)
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The global enteral medical nutrition market based on indication, is segmented into respiratory disorders, cancer, post COVID-19, gastrointestinal disorders, liver failure, others. The respiratory disorders segment held the largest share of the market in 2021. However, the cancer segment is expected to register the highest CAGR during the forecast period.
The enteral medical nutrition market majorly consists of the players such as Abbott Laboratories; Nutricia; Fresenius Kabi AG; B. Braun Melsungen AG; NESTLE S.A.; Meiji Holdings Co., Ltd.; Smartfish AS; DSM; Hormel Foods Corporation; and Global Health Products, Inc.
Factors such as the prevalence of cachexia and the rise in the prevalence of gastrointestinal diseases drive the market growth. However, the complications associated with enteral medical nutrition hamper the growth of the market.
Enteral nutrition refers to any method of feeding that uses the gastrointestinal (GI) tract to deliver nutrition and calories. It can include a normal oral diet, the use of liquid supplements, or delivery by use of a tube (tube feeding). According to the American College of Gastroenterology, there are six main types of feeding tubes. These tubes may have further subtypes depending on exactly where they end in the stomach or intestines.
The List of Companies - Enteral Medical Nutrition Market
- Abbott Laboratories
- Nutricia
- Fresenius Kabi AG
- B. Braun Melsungen AG
- NESTLE S.A.
- Meiji Holdings Co., Ltd.
- Smartfish AS
- DSM
- Hormel Foods Corporation
- Global Health Products, Inc.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.